       Document 0658
 DOCN  M95A0658
 TI    Boxwood. 
 DT    9510
 SO    Treat Rev. 1995 Mar/Apr;(no 17):7. Unique Identifier : AIDSLINE
       AIDS/95700325
 AB    An extract of SPV-30, a herbal compound called Boxwood, has exhibited
       anti-HIV activity in lab tests and a small, placebo controlled trial.
       Arkopharma, the French company that makes the extract, has agreed to
       donate Boxwood for ten informal studies in the U.S. Each study will
       enroll forty to fifty people and last six months. Information can be
       obtained by calling David Stokes at (617) 424-9195. Participants will
       need blood tests, a PCR test, or a p24 antigen test. Patients who have
       just started new medications must wait two months before starting
       SPV-30, and they will have to change their other drug treatments and
       supplements for six months. The Network has buyer club information for
       SPV-30 as well as information about the study, should someone have
       trouble providing the blood tests required, or if their insurance does
       not cover the cost of the blood work.
 DE    CD4 Lymphocyte Count  HIV Seropositivity/BLOOD/*THERAPY  Human  Plant
       Extracts/*THERAPEUTIC USE  Polymerase Chain Reaction  NEWSLETTER ARTICLE
       CLINICAL TRIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

